Tenax Therapeutics, Inc. (TENX) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 0.41 |
| Altman Z-Score | -3.08 (distress) |
| Sector P/E (Healthcare) | 21.7 |
TENX overview · TENX earnings · TENX KPIs · TENX investor relations · TENX ownership · TENX peers · TENX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.